On a descriptive level, the PARK2 CNV duplication carrier/ADHD under baseline conditions seemed to show a more elongated mitochondrial shape and increased tubular branching compared to PARK2 CNV deletion carriers/ADHD and WT control and ADHD. The gene discussed is PRKN; the disease is attention deficit-hyperactivity disorder.